Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy (Adeshakin AO et al, 2021, Ref 136). Here, SLC27A2 is linked to neoplasm.